P3 Health Partners Inc. (NASDAQ:PIII) Stock Short Interest Falls 50.4%

P3 Health Partners Inc. (NASDAQ:PIII) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 13,637 shares, a decrease of 50.4% from the September 15th total of 27,498 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average trading volume of 10,090 shares, the days-to-cover ratio is currently 1.4 days.

Insiders Place Their Bets

In other news, major shareholder Hudson Vegas Investment Spv, L sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $16.48, for a total transaction of $824,000.00. Following the completion of the sale, the insider owned 48,959 shares in the company, valued at $806,844.32. The trade was a 50.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 10.86% of the stock is currently owned by corporate insiders.

Institutional Trading of P3 Health Partners

An institutional investor recently bought a new stake in P3 Health Partners stock. Lido Advisors LLC acquired a new stake in P3 Health Partners Inc. (NASDAQ:PIII) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,748 shares of the company’s stock, valued at approximately $33,000. Lido Advisors LLC owned 0.15% of P3 Health Partners as of its most recent SEC filing. Institutional investors own 7.75% of the company’s stock.

P3 Health Partners Trading Down 5.3%

PIII traded down $0.23 on Thursday, reaching $4.14. The stock had a trading volume of 42,806 shares, compared to its average volume of 442,747. The firm has a 50-day moving average of $8.41 and a 200-day moving average of $8.31. P3 Health Partners has a fifty-two week low of $1.52 and a fifty-two week high of $16.89. The company has a market capitalization of $30.06 million, a price-to-earnings ratio of -0.13 and a beta of 1.70.

P3 Health Partners (NASDAQ:PIII) last released its quarterly earnings data on Monday, August 10th. The company reported ($0.63) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.89) by $1.26. The firm had revenue of $386.38 million during the quarter, compared to analyst estimates of $377.80 million.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Wall Street Zen raised P3 Health Partners to a “hold” rating in a report on Saturday, July 4th. Lake Street Capital restated a “buy” rating and issued a $23.00 price target on shares of P3 Health Partners in a research note on Tuesday, August 11th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of P3 Health Partners in a research report on Tuesday, August 25th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, P3 Health Partners has an average rating of “Hold” and an average price target of $17.00.

About P3 Health Partners

P3 Health Partners Inc is a physician-led healthcare organization focused on value-based care for older adults, particularly beneficiaries enrolled in Medicare Advantage plans. The company works with primary care physicians, health plans and other healthcare providers to coordinate services and improve patient outcomes while managing the overall cost of care.

P3 supports its network through primary care services, care coordination, clinical programs and technology-enabled population health management.